Literature DB >> 6287777

17 alpha-hydroxylase deficiency syndrome associated with bilateral streak gonads and impaired development of Müllerian ducts derivatives. Report of a case.

J L de Gennes, S Jambart, G Turpin, F Elkik, M Roger.   

Abstract

We report severe 17 alpha-hydroxylase deficiency in a 17 year-old black girl with 46,XX genotype. The diagnosis was suspected because of primary amenorrhoea, absence of sexual maturation, hypertension and hypokalaemia with renal potassium wasting. Endocrine investigation revealed low basal levels of all steroid hormones which require 17 alpha-hydroxylation for biosynthesis (i.e. glucocorticoids, androgens and oestrogens). No increase in their basal levels was seen following adrenal stimulation, indicating a severe block. Plasma concentrations of ACTH, FSH and LH were elevated as were progesterone, 11-deoxycorticosterone and corticosterone. Plasma renin activity was suppressed and aldosterone levels were very low. After 4 months of glucocorticoid replacement therapy, aldosterone was still low, even though the suppression was otherwise effective. Our case is unusual because bilateral streak gonads and impaired development of Müllerian ducts derivatives were also present. To our knowledge, a similar case has never been reported before.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6287777

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  4 in total

1.  Male pseudohermaphroditism due to 17-hydroxylase deficiency.

Authors:  A D'Alberton; E Reschini; T Motta; A Catania
Journal:  J Endocrinol Invest       Date:  1989-03       Impact factor: 4.256

2.  An Unusual Case: The Comorbidity of Mood Disorder and 17-α-Hydroxylase Deficiency.

Authors:  Serhat Tunç; Sera Yiğiter; Kürşat Altinbaş; Erhan Kurt; Timuçin Oral
Journal:  Noro Psikiyatr Ars       Date:  2013-09-01       Impact factor: 1.339

3.  17 alpha-Hydroxylase deficiency with persistence of müllerian ducts in a genotypic male and paradoxical aldosterone secretion.

Authors:  N S Panesar; V T Yeung; J C Chan; C C Shek; M G Nicholls; C S Cockram
Journal:  Postgrad Med J       Date:  1993-02       Impact factor: 2.401

4.  Lack of effect in vivo of clofibrate on adrenal steroid secretion.

Authors:  H M Heshmati; G Turpin; Y Touitou; J Varsaux; M Roger; K Nahoul; A Bogdan; A Auzeby
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.